학술논문
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies
Document Type
Artikel
Author
Source
ACR open rheumatology. 5(4):227-240
Subject
Language
English
English
English
ISSN
2578-5745